181 related articles for article (PubMed ID: 6807878)
1. Comparison of serum erythromycin concentration following administration of 100 mg erythromycin ethyl succinate intramuscularly and 500 mg erythromycin stearate orally.
McGimpsey JG; Webb CH; McCrea PH
Int J Oral Surg; 1981; 10(Suppl 1):198-202. PubMed ID: 6807878
[TBL] [Abstract][Full Text] [Related]
2. [Study on serum and urine concentrations of erythromycin succinate of pyrrolidine-methyl-tetracycline].
Nuzzolo L; Sanguigni S; Pierangeli L; Longhi M
Arch Sci Med (Torino); 1968 Sep; 125(9):403-5. PubMed ID: 17340794
[TBL] [Abstract][Full Text] [Related]
3. Erythromycin levels in serum during treatment with erythromycin stearate and base.
Saarni H; Kanto J; Allonen H
Ann Clin Res; 1979 Oct; 11(5):196-8. PubMed ID: 397800
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
[TBL] [Abstract][Full Text] [Related]
5. Absorption of erythromycin. A cross-over study in healthy volunteers.
Männistö P; Tuomisto J; Räsänen R
Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445
[TBL] [Abstract][Full Text] [Related]
6. Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives.
Mäntylä R; Ailio A; Allonen H; Kanto J
Ann Clin Res; 1978 Oct; 10(5):258-62. PubMed ID: 367255
[TBL] [Abstract][Full Text] [Related]
7. Relative bioavailability of enteric coated pellets, stearate and ethylsuccinate formulations of erythromycin.
Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L; Josefsson K
Pharmacology; 1984; 29(6):305-11. PubMed ID: 6334320
[TBL] [Abstract][Full Text] [Related]
8. The pharmacokinetics and tolerance of oral erythromycin stearate compared with erythromycin ethylsuccinate: implications for preventing endocarditis.
Shanson DC; Tidbury P; McNabb WR; Tadayon M
J Antimicrob Chemother; 1984 Aug; 14(2):157-63. PubMed ID: 6334070
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous erythromycin lactobionate.
Parsons RL; David JA; Raymond K; Stamp SM
J Int Med Res; 1980; 8 Suppl 2():15-23. PubMed ID: 6968696
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of erythromycin ethylsuccinate after intragastric administration to healthy foals.
Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
Vet Ther; 2002; 3(2):189-95. PubMed ID: 19750750
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and mammary residual depletion of erythromycin in healthy lactating ewes.
Goudah A; Sher Shah S; Shin HC; Shim JH; Abd El-Aty AM
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):607-11. PubMed ID: 18045347
[TBL] [Abstract][Full Text] [Related]
13. Influence of alcohol consumption on erythromycin ethylsuccinate kinetics.
Morasso MI; Chávez J; Gai MN; Arancibia A
Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):426-9. PubMed ID: 2258252
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and tissue residue profiles of erythromycin in broiler chickens after different routes of administration.
Goudah A; Abo El Sooud K; Abd El-Aty AM
Dtsch Tierarztl Wochenschr; 2004 Apr; 111(4):162-5. PubMed ID: 15171602
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of erythromycin in nonlactating and lactating goats after intravenous and intramuscular administration.
Ambros L; Montoya L; Kreil V; Waxman S; Albarellos G; Rebuelto M; Hallu R; San Andres MI
J Vet Pharmacol Ther; 2007 Feb; 30(1):80-5. PubMed ID: 17217406
[TBL] [Abstract][Full Text] [Related]
16. [Tolerance and effectiveness of oral erythromycin ethyl succinate, intravenous Lactobionate and erythromycin base in infants and small children].
Krepler P; Steinwenter A
Arch Kinderheilkd; 1970 Jan; 180(2):129-50. PubMed ID: 5443953
[No Abstract] [Full Text] [Related]
17. Influence of food on the absorption of flurithromycin in man.
Lepore AM; Bonardi G; Maggi GC
Int J Clin Pharmacol Res; 1988; 8(4):253-7. PubMed ID: 3182114
[TBL] [Abstract][Full Text] [Related]
18. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
De Bernardi M; Feletti F; Gazzani G; Fregnan GB
Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299
[TBL] [Abstract][Full Text] [Related]
19. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
Darwish M; Tempero K; Kirby M; Thompson J
Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of Erythromycin Stearate (CAS No. 643-22-1) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1988 Dec; 338():1-167. PubMed ID: 12732898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
